233 related articles for article (PubMed ID: 33551197)
1. Crowdsourcing to measure financial toxicity in gynecologic oncology.
Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
[TBL] [Abstract][Full Text] [Related]
2. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
[TBL] [Abstract][Full Text] [Related]
4. Evaluating meaningful levels of financial toxicity in gynecologic cancers.
Esselen KM; Gompers A; Hacker MR; Bouberhan S; Shea M; Summerlin SS; Rucker LR; Huh WK; Pisu M; Liang MI
Int J Gynecol Cancer; 2021 Jun; 31(6):801-806. PubMed ID: 33858954
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
Support Care Cancer; 2022 Mar; 30(3):2713-2721. PubMed ID: 34822002
[TBL] [Abstract][Full Text] [Related]
6. Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
Liang MI; Pisu M; Summerlin SS; Boitano TKL; Blanchard CT; Bhatia S; Huh WK
Gynecol Oncol; 2020 Feb; 156(2):271-277. PubMed ID: 31771866
[TBL] [Abstract][Full Text] [Related]
7. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.
Bailey CM; Asaad M; Boukovalas S; Lin YL; Kothamasu V; Kapur SK; Villa MT; Butler CE; Offodile AC
Plast Reconstr Surg; 2021 Jul; 148(1):1e-11e. PubMed ID: 34181599
[TBL] [Abstract][Full Text] [Related]
9. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
[TBL] [Abstract][Full Text] [Related]
10. Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.
Chen YS; Zhou ZN; Glynn SM; Frey MK; Balogun OD; Kanis M; Holcomb K; Gorelick C; Thomas C; Christos PJ; Chapman-Davis E
Cancer; 2021 Jul; 127(14):2399-2408. PubMed ID: 33899220
[TBL] [Abstract][Full Text] [Related]
11. Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States.
Albright BB; Nitecki R; Chino F; Chino JP; Havrilesky LJ; Aviki EM; Moss HA
Am J Obstet Gynecol; 2022 Mar; 226(3):384.e1-384.e13. PubMed ID: 34597606
[TBL] [Abstract][Full Text] [Related]
12. Insurance Coverage, Employment Status, and Financial Well-Being of Young Women Diagnosed with Breast Cancer.
Tangka FKL; Subramanian S; Jones M; Edwards P; Flanigan T; Kaganova Y; Smith KW; Thomas CC; Hawkins NA; Rodriguez J; Fairley T; Guy GP
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):616-624. PubMed ID: 32132129
[TBL] [Abstract][Full Text] [Related]
13. Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers.
Ko EM; Bekelman JE; Hicks-Courant K; Brensinger CM; Kanter GP
Gynecol Oncol; 2022 Feb; 164(2):295-303. PubMed ID: 34949437
[TBL] [Abstract][Full Text] [Related]
14. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
[TBL] [Abstract][Full Text] [Related]
15. Association of Health Insurance Literacy With Financial Hardship in Patients With Cancer.
Khera N; Zhang N; Hilal T; Durani U; Lee M; Padman R; Voleti S; Warsame RM; Borah BJ; Yabroff KR; Griffin JM
JAMA Netw Open; 2022 Jul; 5(7):e2223141. PubMed ID: 35877122
[TBL] [Abstract][Full Text] [Related]
16. Insurance-based disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations.
Ng AP; Sanaiha Y; Verma A; Lee C; Akhavan A; Cohen JG; Benharash P
Gynecol Oncol; 2022 Aug; 166(2):200-206. PubMed ID: 35660294
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for financial toxicity in patients with gynecologic cancer.
Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL; Broach V; Chi DS; Jewell EL; Leitao MM; Long Roche K; Mueller JJ; Sonoda Y; Zivanovic O; Gardner GJ; Abu-Rustum NR
Am J Obstet Gynecol; 2022 Jun; 226(6):817.e1-817.e9. PubMed ID: 34902319
[TBL] [Abstract][Full Text] [Related]
18. Financial toxicity in gynecologic oncology: a multi-practice survey.
Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
Int J Gynecol Cancer; 2024 Feb; ():. PubMed ID: 38346844
[TBL] [Abstract][Full Text] [Related]
19. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors.
Benedict C; Fisher S; Schapira L; Chao S; Sackeyfio S; Sullivan T; Pollom E; Berek JS; Kurian AW; Palesh O
Psychooncology; 2022 Jan; 31(1):9-20. PubMed ID: 34224603
[TBL] [Abstract][Full Text] [Related]
20. Health Insurance Literacy and Financial Hardship in Women Living With Metastatic Breast Cancer.
Williams CP; Pisu M; Azuero A; Kenzik KM; Nipp RD; Aswani MS; Mennemeyer ST; Pierce JY; Rocque GB
JCO Oncol Pract; 2020 Jun; 16(6):e529-e537. PubMed ID: 32048931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
